floxamic neo 5,00 mg/ml krople do oczu, roztwór
zakłady farmaceutyczne polpharma s.a. - moxifloxacinum - krople do oczu, roztwór - 5,00 mg/ml
clindamycin mylan 300 mg kapsułki twarde
viatris ltd - clindamycinum - kapsułki twarde - 300 mg
vaxneuvance
merck sharp & dohme b.v. - pneumococcal polysaccharide conjugate vaccine (adsorbed) - infekcje pneumokokowe - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. zobacz rozdziały 4. 4 i 5. 1 w celu uzyskania informacji na temat ochrony przed określonymi serotypami pneumokokowymi. the use of vaxneuvance should be in accordance with official recommendations.
moxifloxacinum stulln 5 mg/ml krople do oczu, roztwór w pojemniku jednodawkowym
pharma stulln gmbh - moxifloxacini hydrochloridum - krople do oczu, roztwór w pojemniku jednodawkowym - 5 mg/ml
moxifloxacinum stulln 5 mg/ml krople do oczu, roztwór
pharma stulln gmbh - moxifloxacini hydrochloridum - krople do oczu, roztwór - 5 mg/ml
ebglyss
almirall, s.a. - lebrikizumab - zapalenie skóry, atopowe - inne preparaty dermatologiczne - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.